DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up
DVA's robust Dialysis patient service revenues drives its third-quarter performance.
DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript
DaVita Inc. (NYSE:DVA ) Q3 2024 Earnings Conference Call October 29, 2024 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier Rodriguez - Chief Executive O...
DVA Q3 Estimates Unchanged Before Earnings: How to Play the Stock?
Improvement in RPT is likely to have boosted DaVita's top line in the third quarter.
DaVita HealthCare (DVA) Increases Despite Market Slip: Here's What You Need to Know
DaVita HealthCare (DVA) concluded the recent trading session at $163.16, signifying a +1% move from its prior day's close.
Can DaVita Stock Continue Its Bull Run After Doubling in a Year?
DVA stock has the potential to continue its uptrend on the back of better revenues per treatment as well as growth of the overall dialysis market.
DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call
DENVER , Oct. 9, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, October 29, 2024, at 5:00...
DaVita Prepares Thousands of Dialysis Patients for Hurricane Milton
TAMPA , Oct. 8, 2024 /PRNewswire/ -- DaVita Kidney Care , a leading provider of kidney care services, has activated its emergency response plan in preparation for Hurricane Milton's landfall in Fl...
5 Stocks Trading Near 52-Week High With Room to Rise Further
Investors target stocks that have been on a bullish run lately. Stocks like THC, SLVM, DVA, NCLH and IAG are seeing price strength, and the momentum is likely to continue.
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors
DaVita HealthCare (DVA) closed the most recent trading day at $163.08, moving +0.51% from the previous trading session.
3 Stocks Warren Buffett Owns More Than 10% of Right Now
In August, Warren Buffett's Berkshire Hathaway (NYSE: BRK-B) became the first non-tech U.S.
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
In the most recent trading session, DaVita HealthCare (DVA) closed at $164.22, indicating a -0.59% shift from the previous trading day.
3 Red Hot Stocks Flashing Buy Signals: DVA, ISRG, SN
Stocks making new highs tend to make even higher highs, particularly when positive earnings estimate revisions hit the tape. And that's precisely what these three companies have seen.
DaVita Inc. (DVA) Soars to 52-Week High, Time to Cash Out?
DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DaVita Rallies 44% Year to Date: What's Driving the Stock?
DVA's shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
3 Defensive Stocks Outperforming in a Choppy Market (PM, DVA, STWD)
Broad markets, although continuing to trend higher, are showing signs of increasing volatility and uncertainty. While there has been a strong rally in stocks since the sharp correction earlier in t...
Related Companies